Patients with difficult-to-diagnose conditions like endometriosis are often sent home with diagnoses like anxiety or bipolar ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Aspartame already is on the hot seat in Europe; sucralose, saccharin, ace-K and sugar alcohols also have skeletons in their ...
Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in ...
All hail King Blobfish! The annual Fish of the Year 2025 competition came to a dramatic close yesterday, with deep sea rivals orange roughy and blobfish campaigning hard right up to the last minute.
This prospective open-label, randomised study found using mpMRI in the muscle-invasive bladder cancer pathway reduced the time to correct treatment by 45 days compared to standard investigation. The ...
Dysautonomia refers to a group of disorders involving nerves that control heart rate, breathing, and other involuntary functions. Dysautonomia can be difficult to diagnose, in part because symptoms ...
Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...
Get Instant Summarized Text (Gist) A new AI model has been developed to enhance the prediction of chemotherapy responses in muscle-invasive bladder cancer patients. By integrating whole-slide ...